Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Oxford BioDynamics ( (GB:OBD) ) has shared an update.
Oxford BioDynamics has partnered with Regina Maria, Romania’s largest private healthcare provider, to offer its EpiSwitch PSE and CiRT clinical tests in Romania. This agreement allows Regina Maria to market and distribute these tests, enhancing their oncology portfolio and providing Romanian patients with access to high-accuracy diagnostic tests. The collaboration marks a strategic move for Oxford BioDynamics to expand its market presence in the EU, offering innovative solutions for prostate cancer screening and cancer immunotherapy response, thereby reinforcing Regina Maria’s position as a leader in next-generation health services.
More about Oxford BioDynamics
Oxford BioDynamics is a precision clinical diagnostics company that specializes in developing specific and sensitive medical tests using its EpiSwitch 3D genomics platform. The company focuses on bringing advanced diagnostic solutions to the medical field.
YTD Price Performance: -66.67%
Average Trading Volume: 11,717,279
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £9.98M
See more data about OBD stock on TipRanks’ Stock Analysis page.